Clinical trial
Feasibility of Transepicardial Atrial Injection of Saline at the Time Open Chest Cardiac Surgery
NCT05634213 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility of Transepicardial Atrial Injection of Saline at the Time Open Chest Cardiac Surgery
- Lead sponsor
- Ottawa Heart Institute Research Corporation
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- March 1, 2023
- Completion date
- April 1, 2025
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac surgery